Company news
MannKind Corporation news in 2020
MannKind Corporation's news releases, calls and decks from 2020, newest first.
MannKind and Vertice to Co-Promote Thyquidity™ (levothyroxine sodium) Oral Solution
December 16, 2020
James S. Shannon Transitions to Chairman of the Board of Directors for MannKind
December 9, 2020
MannKind Expands Its Pipeline with the Acquisition of QrumPharma, Inc.
December 6, 2020
MannKind and MidCap Amend Credit Facility
November 30, 2020
Sabrina Kay Appointed to MannKind Board of Directors
November 29, 2020
MannKind Receives Fourth $12.5 Million Milestone Payment from United Therapeutics
November 18, 2020
MannKind Corporation Reports 2020 Third Quarter Financial Results
November 3, 2020
MannKind Corporation to Hold 2020 Third Quarter Financial Results Conference Call on November 4, 2020
October 28, 2020
Kevin Kaiserman Joins MannKind as Vice President, Medical Affairs and Safety
August 30, 2020
MannKind Corporation to Participate in BTIG Virtual Biotechnology Conference 2020
August 6, 2020
MannKind Corporation Reports 2020 Second Quarter Financial Results
August 4, 2020
MannKind Corporation to Hold 2020 Second Quarter Financial Results Conference Call on August 5, 2020
July 28, 2020
Alejandro Galindo Joins MannKind as Chief Commercial Officer
July 19, 2020
MannKind Corporation to Present at the June 2020 Lytham Partners Virtual Investor Growth Conference
June 16, 2020
MannKind Presents Positive Original Analyses of Afrezza® Clinical Data at American Diabetes Association (ADA) 80th Scientific Sessions
June 14, 2020
Investigator-Initiated Study Shows Switching to Afrezza® Improves Glucose Control with No Additional Hypoglycemia in T2DM
June 12, 2020
MannKind Corporation Reports 2020 First Quarter Financial Results
May 5, 2020
MannKind Corporation to Hold 2020 First Quarter Financial Results Conference Call on May 6, 2020
April 28, 2020
MannKind Receives Forgivable Loan under the Paycheck Protection Program
April 14, 2020
Jennifer Grancio Appointed to MannKind Board of Directors
March 23, 2020
MannKind Refocuses Pipeline Resources in Response to COVID-19 Pandemic
March 16, 2020
MannKind Corporation Reports 2019 Fourth Quarter and Full Year Financial Results
February 24, 2020
MannKind Corporation to Present at the 9th Annual SVB Leerink Global Healthcare Conference
February 23, 2020
MannKind Presents Novel Scientific Data at 13th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2020)
February 19, 2020
MannKind Corporation to Hold 2019 Fourth Quarter and Full Year Financial Results Conference Call on February 25, 2020
February 17, 2020
Afrezza® (insulin human) Inhalation Powder Receives Pricing Registration in Brazil Commercial activities to commence this month
January 5, 2020